I do think it would be difficult for AXIM to merge with Verséa Health. AXIM would probably want it to be a 50-50 merger. Verséa Health would probably want a bigger chunk than 50%.
On the other hand the AXIM patents and cancer research might be the glue that could make a 50-50 merger at least attractive.
It is fun to speculate when we have a slow news week. Actually the big picture the past 2 months has produced a ton of big news items.
Auer Precision agreement Weekly customer announcements Additional order of reader machines.